Tag: Good Manufacturing Practice (GMP)

WHO GMP and the Role of Documentation and Record-Keeping

Posted on By digi

WHO GMP and the Role of Documentation and Record-Keeping The Critical Role of Documentation and Record-Keeping in WHO GMP Compliance Introduction to Documentation in WHO GMP Documentation and record-keeping are cornerstones of the World Health Organization (WHO)’s Good Manufacturing Practices (GMP)) framework. They ensure traceability, accountability, and compliance in pharmaceutical manufacturing. Proper documentation serves as…

Read More “WHO GMP and the Role of Documentation and Record-Keeping” »

WHO GMP Guidelines

How ANVISA GMP Helps Prevent Pharmaceutical Contamination in Brazil

Posted on By digi

How ANVISA GMP Helps Prevent Pharmaceutical Contamination in Brazil How ANVISA GMP Helps Prevent Pharmaceutical Contamination in Brazil Introduction to ANVISA GMP and Pharmaceutical Contamination The National Health Surveillance Agency (ANVISA) is Brazil’s regulatory authority responsible for overseeing the safety, efficacy, and quality of pharmaceutical products. One of the primary ways ANVISA ensures drug safety…

Read More “How ANVISA GMP Helps Prevent Pharmaceutical Contamination in Brazil” »

GMP in Latin America (ANVISA, COFEPRIS)

How TGA GMP Affects Pharmaceutical Manufacturing Risk Management

Posted on By digi

How TGA GMP Affects Pharmaceutical Manufacturing Risk Management The Role of TGA GMP in Pharmaceutical Risk Management Introduction to TGA GMP and Risk Management Pharmaceutical manufacturing is inherently complex, involving numerous processes, raw materials, and regulatory requirements. Ensuring product safety, efficacy, and quality requires effective risk management strategies. The Therapeutic Goods Administration (TGA) enforces stringent…

Read More “How TGA GMP Affects Pharmaceutical Manufacturing Risk Management” »

TGA GMP Guidelines

Schedule M (Revised) GMP for the Manufacture of Biologics and Biosimilars

Posted on By digi

Schedule M (Revised) GMP for the Manufacture of Biologics and Biosimilars Ensuring Quality and Compliance in the Manufacture of Biologics and Biosimilars Under Schedule M (Revised) GMP Introduction to Biologics, Biosimilars, and Schedule M (Revised) Biologics and biosimilars are among the most advanced pharmaceutical products, offering targeted treatments for diseases such as cancer, autoimmune disorders,…

Read More “Schedule M (Revised) GMP for the Manufacture of Biologics and Biosimilars” »

SCHEDULE - M - Revised

The Challenges of PMDA GMP Compliance in the Pharmaceutical Industry

Posted on By digi

The Challenges of PMDA GMP Compliance in the Pharmaceutical Industry The Challenges of PMDA GMP Compliance in the Pharmaceutical Industry Introduction to PMDA GMP Compliance Good Manufacturing Practices (GMP) are essential to ensuring that pharmaceutical products are consistently produced and controlled according to quality standards. In Japan, the Pharmaceutical and Medical Devices Agency (PMDA) is…

Read More “The Challenges of PMDA GMP Compliance in the Pharmaceutical Industry” »

PMDA GMP Guidelines

How NMPA GMP Helps Manage Risk in Pharmaceutical Manufacturing

Posted on By digi

How NMPA GMP Helps Manage Risk in Pharmaceutical Manufacturing How NMPA GMP Helps Manage Risk in Pharmaceutical Manufacturing Introduction to NMPA GMP and Risk Management The pharmaceutical industry is one of the most heavily regulated sectors globally due to the potential risks associated with drug manufacturing, distribution, and usage. Ensuring the safety, efficacy, and quality…

Read More “How NMPA GMP Helps Manage Risk in Pharmaceutical Manufacturing” »

NMPA GMP Guidelines

Best Practices for Ensuring EMA GMP Compliance in Pharmaceutical R&D

Posted on By digi

Best Practices for Ensuring EMA GMP Compliance in Pharmaceutical R&D Ensuring EMA GMP Compliance in Pharmaceutical Research and Development Introduction to EMA GMP in Pharmaceutical R&D Pharmaceutical research and development (R&D) is the foundation of creating innovative drugs that improve patient outcomes. While R&D primarily focuses on discovery and preclinical studies, compliance with the European…

Read More “Best Practices for Ensuring EMA GMP Compliance in Pharmaceutical R&D” »

EMA GMP Guidelines

How to Use WHO GMP Guidelines to Improve Manufacturing Efficiency

Posted on By digi

How to Use WHO GMP Guidelines to Improve Manufacturing Efficiency Enhancing Manufacturing Efficiency with WHO GMP Guidelines Introduction to Manufacturing Efficiency and WHO GMP Manufacturing efficiency is a cornerstone of the pharmaceutical industry, ensuring the consistent production of high-quality medicines while optimizing resources and minimizing costs. The World Health Organization (WHO)’s Good Manufacturing Practices (GMP))…

Read More “How to Use WHO GMP Guidelines to Improve Manufacturing Efficiency” »

WHO GMP Guidelines

MHRA GMP Guidelines for Clinical Manufacturing: What Pharma Companies Need to Know

Posted on By digi

MHRA GMP Guidelines for Clinical Manufacturing: What Pharma Companies Need to Know Understanding MHRA GMP Guidelines for Clinical Manufacturing Introduction to Clinical Manufacturing and MHRA GMP Clinical manufacturing refers to the production of investigational medicinal products (IMPs) used in clinical trials. These products are critical for evaluating the safety, efficacy, and quality of new drugs…

Read More “MHRA GMP Guidelines for Clinical Manufacturing: What Pharma Companies Need to Know” »

MHRA GMP Guidelines

The Role of TGA GMP in Quality Assurance and Control

Posted on By digi

The Role of TGA GMP in Quality Assurance and Control How TGA GMP Ensures Excellence in Quality Assurance and Control Introduction to TGA GMP and Quality Assurance The Therapeutic Goods Administration (TGA) enforces stringent Good Manufacturing Practices (GMP) to regulate the production and distribution of pharmaceutical products in Australia. A cornerstone of TGA GMP compliance…

Read More “The Role of TGA GMP in Quality Assurance and Control” »

TGA GMP Guidelines